title: Medical nutrition therapy: use of sourdough lactic acid bacteria as a cell factory for delivering functional biomolecules and food ingredients in gluten free bread.
abstract: Celiac disease (CD) is an immune-mediated disease, triggered in genetically susceptible individuals by ingesting gluten from wheat, rye, barley, and other closely related cereal grains. Currently, the estimated prevalence of CD is around 1 % of the population in the western world and medical nutritional therapy (MNT) is the only accepted treatment for celiac disease. To date, the replacement of gluten in bread presents a significant technological challenge for the cereal scientist due to the low baking performance of gluten free products (GF). The increasing demand by the consumer for high quality gluten-free (GF) bread, clean labels and natural products is rising. Sourdough has been used since ancient times for the production of rye and wheat bread, its universal usage can be attributed to the improved quality, nutritional properties and shelf life of sourdough based breads. Consequently, the exploitation of sourdough for the production of GF breads appears tempting. This review will highlight how sourdough LAB can be an efficient cell factory for delivering functional biomolecules and food ingredients to enhance the quality of gluten free bread.
authors: School of Food and Nutritional Sciences, University College Cork, Western Road, Cork, Ireland. e.arendt@ucc.ie
authors: Elke K
authors: EK
authors: Arendt
authors: Alice
authors: A
authors: Moroni
authors: Emanuele
authors: E
authors: Zannini
mesh_terms: D001939:Bread / Q000382:microbiology*; D002446:Celiac Disease / Q000178:diet therapy* / Q000473:pathology; D005285:Fermentation; D005516:Food Microbiology; D005983:Glutens; D006801:Humans; D019344:Lactic Acid / Q000378:metabolism*; D056546:Lactobacillales / Q000378:metabolism*; D044623:Nutrition Therapy
chemical_list: D019344:Lactic Acid; D005983:Glutens